comparemela.com

Latest Breaking News On - Pulmonx daily - Page 8 : comparemela.com

Pulmonx Co (NASDAQ:LUNG) Receives $13 29 Average Target Price from Analysts

Pulmonx Co (NASDAQ:LUNG) Receives $13 29 Average Target Price from Analysts
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Allspring Global Investments Holdings LLC Acquires 3,062 Shares of Pulmonx Co (NASDAQ:LUNG)

Allspring Global Investments Holdings LLC boosted its holdings in shares of Pulmonx Co. (NASDAQ:LUNG – Free Report) by 257.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,251 shares of the company’s stock after purchasing an additional 3,062 shares during […]

Pulmonx Co (NASDAQ:LUNG) Short Interest Up 5 7% in October

Pulmonx Co. (NASDAQ:LUNG – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 1,300,000 shares, an increase of 5.7% from the October 15th total of 1,230,000 shares. Based on an average daily trading volume, of 196,000 shares, […]

Pulmonx (NASDAQ:LUNG) Given New $13 00 Price Target at Piper Sandler

Pulmonx (NASDAQ:LUNG – Free Report) had its price target lowered by Piper Sandler from $17.00 to $13.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Other equities research analysts have also issued reports about the company. Citigroup increased their target price […]

Pulmonx (NASDAQ:LUNG) Releases Earnings Results

Pulmonx (NASDAQ:LUNG – Get Free Report) posted its earnings results on Monday. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.45) by $0.06, Briefing.com reports. The firm had revenue of $17.67 million for the quarter, compared to analysts’ expectations of $16.67 million. Pulmonx had a negative return on equity of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.